Advanced in WT1-Related Wilms Tumor Syndromes

Dr. Heather A. Jacene

Nuclear Medicine | Radiology
Mass General Brigham
Brigham And Womens Physicians Organization Inc
75 Francis St, 
Boston, MA 

Advanced in WT1-Related Wilms Tumor Syndromes
Mass General Brigham
Brigham And Womens Physicians Organization Inc
75 Francis St, 
Boston, MA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Heather Jacene is a Nuclear Medicine specialist and a Radiologist in Boston, Massachusetts. Dr. Jacene is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. Her top areas of expertise are Neuroendocrine Tumor, Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET), Muscle Invasive Bladder Cancer, WT1-Related Wilms Tumor Syndromes, and Prostatectomy.

Her clinical research consists of co-authoring 120 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Nuclear Medicine
Radiology
Licenses
Nuclear Medicine in MA
Hospital Affiliations
Brigham And Women's Hospital
Brigham And Women's Faulkner Hospital
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

BRIGHAM AND WOMENS PHYSICIANS ORGANIZATION INC
75 Francis St, Boston, MA 02115
Call: 617-732-5500
Other Locations
DANA-FARBER CANCER INSTITUTE, INC.
450 Brookline Ave, Boston, MA 02215
Call: 617-632-3586

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


6 Clinical Trials

A Phase I Trial of Triapine and Lutetium Lu 177 Dotatate in Combination for Well-Differentiated Somatostatin Receptor-Positive Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)
A Phase I Trial of Triapine and Lutetium Lu 177 Dotatate in Combination for Well-Differentiated Somatostatin Receptor-Positive Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)
Enrollment Status: Active_not_recruiting
Publish Date: September 18, 2025
Intervention Type: Procedure, Drug
Study Drugs: Lutetium Lu 177 Dotatate, Triapine
Study Phase: Phase 1
FDG PET to Assess Therapeutic Response in Patients With Bone-Dominant Metastatic Breast Cancer, FEATURE
FDG PET to Assess Therapeutic Response in Patients With Bone-Dominant Metastatic Breast Cancer, FEATURE
Enrollment Status: Active_not_recruiting
Publish Date: July 10, 2025
Intervention Type: Other, Procedure
Study Phase: Phase 2
A Pilot Study of 18Fluorine-Fluciclovine Positron Emission Tomography/Computed Tomography for Staging Muscle Invasive Bladder Cancer Preceding Radical Cystectomy
A Pilot Study of 18Fluorine-Fluciclovine Positron Emission Tomography/Computed Tomography for Staging Muscle Invasive Bladder Cancer Preceding Radical Cystectomy
Enrollment Status: Active_not_recruiting
Publish Date: February 05, 2025
Intervention Type: Drug, Device
Study Drug: 18F-Fluciclovine
Study Phase: Early Phase 1
A Phase II, Open Label, Multi-Dose Study of ⁸⁹Zr-Df-IAB22M2C (CD8 PET Tracer) for Positron Emission Tomography (PET/CT) in Patients With Selected Advanced or Metastatic Solid Malignancies Who Are Scheduled to Receive Standard-of-Care Immunotherapy Only, As Single Agent or in Combination
A Phase II, Open Label, Multi-Dose Study of ⁸⁹Zr-Df-IAB22M2C (CD8 PET Tracer) for Positron Emission Tomography (PET/CT) in Patients With Selected Advanced or Metastatic Solid Malignancies Who Are Scheduled to Receive Standard-of-Care Immunotherapy Only, As Single Agent or in Combination
Enrollment Status: Completed
Publish Date: July 09, 2024
Intervention Type: Drug
Study Drug: 89Zr-Df-IAB22M2C
Study Phase: Phase 2
Pilot Study of Zirconium-89 Bevacizumab Positron Emission Tomography for Imaging Angiogenesis in Patients With Inflammatory Breast Carcinoma Receiving Preoperative Chemotherapy
Pilot Study of Zirconium-89 Bevacizumab Positron Emission Tomography for Imaging Angiogenesis in Patients With Inflammatory Breast Carcinoma Receiving Preoperative Chemotherapy
Enrollment Status: Completed
Publish Date: December 12, 2019
Intervention Type: Drug, Procedure
Study Phase: Early Phase 1
A Phase I/II Study of I-131 Tositumomab in Patients With Relapsed/Refractory Hodgkin's Lymphoma
A Phase I/II Study of I-131 Tositumomab in Patients With Relapsed/Refractory Hodgkin's Lymphoma
Enrollment Status: Completed
Publish Date: August 01, 2018
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
View 5 Less Clinical Trials

120 Total Publications

EA1211: interim FDG-PET/CT for predicting response of HER2-positive breast cancer to neoadjuvant therapy (DIRECT trial).
EA1211: interim FDG-PET/CT for predicting response of HER2-positive breast cancer to neoadjuvant therapy (DIRECT trial).
Journal: Future oncology (London, England)
Published: October 06, 2025
View All 120 Publications
Similar Doctors
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Kemal Tuncali
Radiology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Kemal Tuncali
Radiology

Brigham And Womens Physicians Organization Inc

75 Francis St, 
Boston, MA 
 (0.1 miles away)
617-732-5500
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Kemal Tuncali is a Radiologist in Boston, Massachusetts. Dr. Tuncali is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, Ureterocele, Prostatectomy, and Liver Embolization.

Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Ronald S. Arellano
Interventional Radiology | Radiology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Ronald S. Arellano
Interventional Radiology | Radiology

Massachusetts General Physicians Organization Inc

55 Fruit St, 
Boston, MA 
 (2.7 miles away)
617-724-0287
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Ronald Arellano is an Interventional Radiologist and a Radiologist in Boston, Massachusetts. Dr. Arellano is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Renal Cell Carcinoma (RCC), Fibrolamellar Carcinoma, Ascites, Gastrostomy, and Liver Embolization.

Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Paul B. Shyn
Radiology | Neuroradiology | Pediatric Radiology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Paul B. Shyn
Radiology | Neuroradiology | Pediatric Radiology

Brigham And Womens Physicians Organization Inc

75 Francis St, 
Boston, MA 
 (0.1 miles away)
617-732-5500
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Paul Shyn is a Radiologist and a Neuroradiologist in Boston, Massachusetts. Dr. Shyn is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are WT1-Related Wilms Tumor Syndromes, Renal Cell Carcinoma (RCC), Familial Colorectal Cancer, Cardiac Ablation, and Liver Embolization.

VIEW MORE WT1-RELATED WILMS TUMOR SYNDROMES DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Jacene's expertise for a condition
ConditionClose
    • Distinguished
    • Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
      Dr. Jacene is
      Distinguished
      . Learn about Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET).
      See more Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) experts
    • Muscle Invasive Bladder Cancer
      Dr. Jacene is
      Distinguished
      . Learn about Muscle Invasive Bladder Cancer.
      See more Muscle Invasive Bladder Cancer experts
    • Neuroendocrine Tumor
      Dr. Jacene is
      Distinguished
      . Learn about Neuroendocrine Tumor.
      See more Neuroendocrine Tumor experts
    • Advanced
    • Febrile Neutropenia
      Dr. Jacene is
      Advanced
      . Learn about Febrile Neutropenia.
      See more Febrile Neutropenia experts
    • Mesothelioma
      Dr. Jacene is
      Advanced
      . Learn about Mesothelioma.
      See more Mesothelioma experts
    • Renal Cell Carcinoma (RCC)
      Dr. Jacene is
      Advanced
      . Learn about Renal Cell Carcinoma (RCC).
      See more Renal Cell Carcinoma (RCC) experts
    • WT1-Related Wilms Tumor Syndromes
      Dr. Jacene is
      Advanced
      . Learn about WT1-Related Wilms Tumor Syndromes.
      See more WT1-Related Wilms Tumor Syndromes experts
    • Experienced
    • Adrenal Cancer
      Dr. Jacene is
      Experienced
      . Learn about Adrenal Cancer.
      See more Adrenal Cancer experts
    • ALK-Positive Non-Small Cell Lung Cancer
      Dr. Jacene is
      Experienced
      . Learn about ALK-Positive Non-Small Cell Lung Cancer.
      See more ALK-Positive Non-Small Cell Lung Cancer experts
    • Caffey Disease
      Dr. Jacene is
      Experienced
      . Learn about Caffey Disease.
      See more Caffey Disease experts
    • Classical Hodgkin Lymphoma
      Dr. Jacene is
      Experienced
      . Learn about Classical Hodgkin Lymphoma.
      See more Classical Hodgkin Lymphoma experts
    • Lung Nodules
      Dr. Jacene is
      Experienced
      . Learn about Lung Nodules.
      See more Lung Nodules experts
    • Mantle Cell Lymphoma (MCL)
      Dr. Jacene is
      Experienced
      . Learn about Mantle Cell Lymphoma (MCL).
      See more Mantle Cell Lymphoma (MCL) experts
    View All 18 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2025 All Rights Reserved